Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63.
Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11–20.
Article CAS PubMed Google Scholar
Kang YK, Yook JH, Park YK, Lee JS, Kim YW, Kim JY, et al. Prodigy: a phase III study of neoadjuvant docetaxel, oxaliplatin, and S-1 plus surgery and adjuvant S-1 versus surgery and adjuvant S-1 for resectable advanced gastric cancer. J Clin Oncol. 2021;39:2903–13.
Article CAS PubMed PubMed Central Google Scholar
Zhang X, Liang H, Li Z, Xue Y, Wang Y, Zhou Z, et al. Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial. Lancet Oncol. 2021;22:1081–92.
Article CAS PubMed Google Scholar
Merrill RM, Hunter BD. Conditional survival among cancer patients in the United States. Oncologist. 2010;15:873–82.
Article PubMed PubMed Central Google Scholar
D’Ugo D, Biondi A, Tufo A, Persiani R. Follow-up: the evidence. Dig Surg. 2013;30:159–68.
Aurello P, Petrucciani N, Antolino L, Giulitti D, D’Angelo F, Ramacciato G. Follow-up after curative resection for gastric cancer: is it time to tailor it? World J Gastroenterol. 2017;23:3379–87.
Article PubMed PubMed Central Google Scholar
Huang C, Liu H, Hu Y, Sun Y, Su X, Cao H, et al. Laparoscopic vs open distal gastrectomy for locally advanced gastric cancer: five-year outcomes from the CLASS-01 randomized clinical trial. JAMA Surg. 2022;157:9–17.
Maharjan U, Kauppila JH. Survival trends in gastric cancer patients between 1987 and 2016: a population-based cohort study in Finland. Gastric Cancer. 2022;25:989–1001.
Article PubMed PubMed Central Google Scholar
Kakeji Y, Yoshida K, Kodera Y, Kochi M, Sano T, Ichikawa W, et al. Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07. Gastric Cancer. 2022;25:188–96.
Article CAS PubMed Google Scholar
Wang SJ, Emery R, Fuller CD, Kim JS, Sittig DF, Thomas CR. Conditional survival in gastric cancer: a SEER database analysis. Gastric Cancer. 2007;10:153–8.
Kim Y, Ejaz A, Spolverato G, Squires MH, Poultsides G, Fields RC, et al. Conditional survival after surgical resection of gastric cancer: a multi-institutional analysis of the US gastric cancer collaborative. Ann Surg Oncol. 2015;22:557–64.
Wang P, Sun Z, Wang W, Deng J, Wang Z, Liang H, et al. Conditional survival of patients with gastric cancer who undergo curative resection: a multi-institutional analysis in China. Cancer. 2018;124:916–24.
Bourcier K, Dinart D, Le Cesne A, Honoré C, Meeus P, Blay JY, et al. Outcome of patients with soft-tissue sarcomas: an age-specific conditional survival analysis. Oncologist. 2019;24:e559–64.
Article PubMed PubMed Central Google Scholar
Kwon JH, Jwa EK, Lee JW, Tak E, Hwang S. Development and validation of a dynamic prognostic nomogram for conditional survival in hepatocellular carcinoma: an analysis from the Korea Liver Cancer Registry. Sci Rep. 2025;15:8654.
Article CAS PubMed PubMed Central Google Scholar
Bowles TL, Hu CY, You NY, Skibber JM, Rodriguez-Bigas MA, Chang GJ. An individualized conditional survival calculator for patients with rectal cancer. Dis Colon Rectum. 2013;56:551–9.
Article PubMed PubMed Central Google Scholar
Wang SJ, Wissel AR, Luh JY, Fuller CD, Kalpathy-Cramer J, Thomas CR Jr. An interactive tool for individualized estimation of conditional survival in rectal cancer. Ann Surg Oncol. 2011;18:1547–52.
Article PubMed PubMed Central Google Scholar
Zheng Z, Wang X, Liu Z, Lu X, Huang Y, Chi P. Individualized conditional survival nomograms for patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and radical surgery. Eur J Surg Oncol. 2021;47:3175–81.
Hagens ERC, Feenstra ML, Eshuis WJ, Hulshof M, van Laarhoven HWM, van Berge Henegouwen MI, et al. Conditional survival after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer. Br J Surg. 2020;107:1053–61.
Article CAS PubMed Google Scholar
Mayo SC, Nathan H, Cameron JL, Olino K, Edil BH, Herman JM, et al. Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent. Cancer. 2012;118:2674–81.
Zhang J, Xiang Y, Chen J, Liu L, Jin J, Zhu S. Conditional survival analysis and dynamic prediction of long-term survival in Merkel cell carcinoma patients. Front Med. 2024;11:1354439.
Caverly TJ, Hayward RA. Dealing with the lack of time for detailed shared decision-making in primary care: everyday shared decision-making. J Gen Intern Med. 2020;35:3045–9.
Article PubMed PubMed Central Google Scholar
AbouAyash J, Abdu RW, Kania TA, Feldman H, Kerr J, Johns A, et al. Conditional survival analysis and risk factors for mortality in patients with chronic limb-threatening ischemia. J Vasc Surg. 2025. https://doi.org/10.1016/j.jvs.2025.05.004.
Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2021 (6th edition). Gastric Cancer. 2023;26(1):1–25.
Skuladottir H, Olsen JH. Conditional survival of patients with the four major histologic subgroups of lung cancer in Denmark. J Clin Oncol Off J Am Soc Clin Oncol. 2003;21:3035–40.
Kruchko C, Propp JM, Mccarthy BJ, Davis FG. Conditional probability of survival of children with primary malignant brain and other CNS tumors in the United States: SEER program data, 1975–2002. International Symposium on Pediatric Neuro-Oncology Oxford University Press; 2007;199–200.
Johnson DR, Ma DJ, Buckner JC, Hammack JE. Conditional probability of long-term survival in glioblastoma: a population-based analysis. Cancer. 2012;118:5608–13.
Stephenson AJ, Scardino PT, Eastham JA, Bianco FJ Jr, Dotan ZA, DiBlasio CJ, et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23:7005–12.
Margonis GA, Buettner S, Andreatos N, Wagner D, Sasaki K, Barbon C, et al. Prognostic factors change over time after hepatectomy for colorectal liver metastases: a multi-institutional, international analysis of 1099 patients. Ann Surg. 2019;269:1129–37.
Weiser MR, Chou JF, Kim JK, Widmar M, Wei IH, Pappou EP, et al. A dynamic clinical calculator for estimating conditional recurrence-free survival after total neoadjuvant therapy for rectal cancer and either surgery or watch-and-wait management. JAMA Netw Open. 2022;5:e2233859.
Article PubMed PubMed Central Google Scholar
Cass SH, Tzeng CD, Prakash LR, et al. Trends over time in recurrence patterns and survival outcomes after neoadjuvant therapy and surgery for pancreatic cancer. Ann Surg. Published online March 20, 2024.
Chen QY, Zhong Q, Zhou JF, Qiu XT, Dang XY, Cai LS, et al. Conditional survival and recurrence of remnant gastric cancer after surgical resection: a multi-institutional study. Cancer Sci. 2020;111:502–12.
Article CAS PubMed Google Scholar
Chen QY, Zhong Q, Wang W, Chen S, Li P, Xie JW, et al. Prognosis of young survivors of gastric cancer in China and the U.S.: determining long-term outcomes based on conditional survival. Oncologist. 2019;24:e260–74.
Zamboni BA, Yothers G, Choi M, Fuller CD, Dignam JJ, Raich PC, et al. Conditional survival and the choice of conditioning set for patients with colon cancer: an analysis of NSABP trials C-03 through C-07. J Clin Oncol Off J Am Soc Clin Oncol. 2010;28:2544–8.
Wang JB, Zhong Q, Wang W, Desiderio J, Chen S, Liu ZY, et al. Postoperative dynamic survival of gastric cancer patients: a multi-institutional, international analysis of 22 265 patients. J Surg Oncol. 2019;120:685–97.
Comments (0)